...
首页> 外文期刊>Cancer chemotherapy and pharmacology. >XPG genetic polymorphisms and clinical outcome of patients with advanced non-small cell lung cancer under platinum-based treatment: a meta-analysis of 12 studies
【24h】

XPG genetic polymorphisms and clinical outcome of patients with advanced non-small cell lung cancer under platinum-based treatment: a meta-analysis of 12 studies

机译:基于铂治疗下的晚期非小细胞肺癌患者的XPG遗传多态性及临床结果:12项研究的META分析

获取原文
获取原文并翻译 | 示例
           

摘要

A number of studies on the relationship between xeroderma pigmentosum group G (XPG) polymorphisms and clinical outcomes in non-small cell cancer (NSCLC) have led to inconclusive results. This meta-analysis evaluates the predictive value of XPG polymorphisms on the treatment response rate and overall survival of patients with NSCLC.
机译:许多关于非小细胞癌(NSCLC)中Xeroderma Pigmorys组G(XPG)多态性和临床结果之间关系的研究导致了不确定的结果。 该META分析评估了XPG多态性对NSCLC患者治疗响应率和整体存活的预测值。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号